A
Antonio Passaro
Researcher at European Institute of Oncology
Publications - 125
Citations - 3138
Antonio Passaro is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 19, co-authored 102 publications receiving 1776 citations. Previous affiliations of Antonio Passaro include Sapienza University of Rome & University of Milan.
Papers
More filters
Journal ArticleDOI
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Marina Chiara Garassino,Jennifer G. Whisenant,Li-Ching Huang,Annalisa Trama,Valter Torri,Francesco Agustoni,Javier Baena,Giuseppe Luigi Banna,Rossana Berardi,Anna Cecilia Bettini,Emilio Bria,Matteo Brighenti,Jacques Cadranel,Alessandro De Toma,Claudio Chini,Alessio Cortellini,Enriqueta Felip,Giovanna Finocchiaro,Pilar Garrido,Carlo Genova,Raffaele Giusti,Vanesa Gregorc,Francesco Grossi,Federica Grosso,Salvatore Intagliata,Nicla La Verde,Stephen V. Liu,Julien Mazieres,Edoardo Mercadante,Olivier Michielin,Gabriele Minuti,Denis Moro-Sibilot,Giulia Pasello,Antonio Passaro,Vieri Scotti,Piergiorgio Solli,Elisa Stroppa,Marcello Tiseo,Giuseppe Viscardi,Luca Voltolini,Yi-Long Wu,Silvia Zai,Vera Pancaldi,Anne Marie C. Dingemans,Jan P. van Meerbeeck,Fabrice Barlesi,Heather A. Wakelee,Solange Peters,Leora Horn +48 more
TL;DR: With an ongoing global pandemic of COVID-19, the data suggest high mortality and low admission to intensive care in patients with thoracic cancer and whether mortality could be reduced with treatment in intensive care remains to be determined.
Journal ArticleDOI
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
Giuseppe Curigliano,Susana Banerjee,Andrés Cervantes,Andrés Cervantes,M.C. Garassino,Pilar Garrido,Nicolas Girard,Nicolas Girard,J.B.A.G. Haanen,Karin Jordan,Florian Lordick,J-P. Machiels,Olivier Michielin,Solange Peters,J. Tabernero,J.-Y. Douillard,Georgios Pentheroudakis,Alfredo Addeo,Laurence Albiges,Paolo A. Ascierto,Fabrice Barlesi,C. Caldas,Fatima Cardoso,Iris F. Chaberny,Nathan I. Cherny,Toni K. Choueiri,Melvin L.K. Chua,Melvin L.K. Chua,Carmen Criscitiello,E. de Azambuja,Dirk De Ruysscher,E.G.E. de Vries,Rebecca Dent,D. D’Ugo,Rafal Dziadziuszko,Corinne Faivre-Finn,Enriqueta Felip,Marina Chiara Garassino,R. Glynne-Jones,Vassilis Golfinopoulos,Erika Hamilton,P.A. Jänne,Ravindran Kanesvaran,S.B. Kim,U.G. Liebert,T.S.K. Mok,Gilberto Morgan,R. Obermannova,K. Park,Antonio Passaro,Martin Reck,R. Salazar Soler,R. Salazar Soler,Florian Scotté,Florian Scotté,Suresh Senan,Cristiana Sessa,Elizabeth C Smyth,R. Soo,Jean-Charles Soria,James Spicer,Florian Strasser,D.S.W. Tan,Dario Trapani,E. Van Cutsem,H.K. van Halteren,P. Van Schil,Giulia Veronesi,J. Yang +68 more
TL;DR: An international consortium to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty.
Journal ArticleDOI
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC
Imane Chaib,Niki Karachaliou,Sara Pilotto,Jordi Codony Servat,Xueting Cai,Xueting Cai,X. Li,Ana Drozdowskyj,Carles Codony Servat,Jie Yang,Jie Yang,Chunping Hu,Chunping Hu,Andrés F. Cardona,Guillermo López Vivanco,Alain Vergnenegre,Jose Miguel Sanchez,Mariano Provencio,Filipo de Marinis,Antonio Passaro,Enric Carcereny,Noemi Reguart,Charo Garcia Campelo,Christina Teixido,Isabella Sperduti,Sonia Rodríguez,Chiara Lazzari,Alberto Verlicchi,Itziar de Aguirre,Cristina Queralt,Jia Wei,Roger Estrada,Raimon Puig de la Bellacasa,Jose Luis Ramirez,Kirstine Jacobson,Henrik J. Ditzel,Mariacarmela Santarpia,Mariacarmela Santarpia,Santiago Viteri,Migual Angel Molina,Caicun Zhou,Peng Cao,Peng Cao,Patrick C. Ma,Trever G. Bivona,Rafael Rosell +45 more
TL;DR: This study uncovers a coordinated signaling network centered on both STAT3 and Src-YAP signaling that limits targeted therapy response in lung cancer and identifies an unforeseen rational upfront polytherapy strategy to minimize residual disease and enhance clinical outcomes.
Journal ArticleDOI
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies
Chiara D'Antonio,Antonio Passaro,Bruno Gori,Ester Del Signore,Maria Rita Migliorino,Serena Ricciardi,Alberto Fulvi,Filippo de Marinis +7 more
TL;DR: In patients harboring EGFR mutations, the administration of EGFR TKIs is followed by a response rate of 70–80%, and a longer progression-free and overall survival than those obtained with standard chemotherapeutic regimens, this review is focused on the evidence for therapeutic strategies in bone and brain metastases due to lung cancer.
Journal ArticleDOI
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective.
Matteo Lambertini,Angela Toss,Antonio Passaro,Carmen Criscitiello,Chiara Cremolini,Claudia Cardone,Fotios Loupakis,Giuseppe Viscardi,Giuseppe Viscardi,Icro Meattini,Maria Vittoria Dieci,Roberto Ferrara,Raffaele Giusti,Massimo Di Maio +13 more
TL;DR: In this article, the authors present a discussion of the importance of diversity and diversity in the context of health care, and discuss the benefits of diversity in health care.Click here to listen.